These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
291 related items for PubMed ID: 8372217
1. Extremity osteosarcoma in childhood: prognostic value of radiologic imaging. Lawrence JA, Babyn PS, Chan HS, Thorner PS, Pron GE, Krajbich IJ. Radiology; 1993 Oct; 189(1):43-7. PubMed ID: 8372217 [Abstract] [Full Text] [Related]
3. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma. Byun BH, Kong CB, Lim I, Choi CW, Song WS, Cho WH, Jeon DG, Koh JS, Lee SY, Lim SM. J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899 [Abstract] [Full Text] [Related]
8. [Low grade intramedullary osteosarcoma. Apropos of 8 cases]. Katabi M, Anract P, Forest M, Tomeno B. Rev Chir Orthop Reparatrice Appar Mot; 1996 Mar; 82(3):208-15. PubMed ID: 9005458 [Abstract] [Full Text] [Related]
9. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. Kager L, Zoubek A, Pötschger U, Kastner U, Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M, Winkelmann W, Jundt G, Kabisch H, Reichardt P, Jürgens H, Gadner H, Bielack SS, Cooperative German-Austrian-Swiss Osteosarcoma Study Group. J Clin Oncol; 2003 May 15; 21(10):2011-8. PubMed ID: 12743156 [Abstract] [Full Text] [Related]
10. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy? Bacci G, Picci P, Gherlinzoni F, Van Horn JR, Orlandi M, Normand AR, Manfrini M, Pignatti G, Campanacci M. Chemioterapia; 1986 Apr 15; 5(2):140-3. PubMed ID: 3458546 [Abstract] [Full Text] [Related]
11. Accuracy of MR imaging for estimating intraosseous extent of osteosarcoma. Onikul E, Fletcher BD, Parham DM, Chen G. AJR Am J Roentgenol; 1996 Nov 15; 167(5):1211-5. PubMed ID: 8911182 [Abstract] [Full Text] [Related]
13. [Osteosarcoma: magnetic resonance imaging of the effects of preoperative chemotherapy]. Spina V, Torricelli P, Manfrini M, Picci P, Romagnoli R. Radiol Med; 1993 Jun 15; 85(6):725-32. PubMed ID: 8337428 [Abstract] [Full Text] [Related]
14. Osteosarcoma: the outcome of limb salvage surgery. Faisham WI, Zulmi W, Halim AS, Biswal BM, Mutum SS. Med J Malaysia; 2004 Dec 15; 59 Suppl F():24-34. PubMed ID: 15941157 [Abstract] [Full Text] [Related]
15. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P. Cancer; 2006 Mar 01; 106(5):1154-61. PubMed ID: 16421923 [Abstract] [Full Text] [Related]
18. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. Link MP, Goorin AM, Miser AW, Green AA, Pratt CB, Belasco JB, Pritchard J, Malpas JS, Baker AR, Kirkpatrick JA. N Engl J Med; 1986 Jun 19; 314(25):1600-6. PubMed ID: 3520317 [Abstract] [Full Text] [Related]
19. Preoperative evaluation of osteosarcoma: value of gadopentetate dimeglumine-enhanced MR imaging. Seeger LL, Widoff BE, Bassett LW, Rosen G, Eckardt JJ. AJR Am J Roentgenol; 1991 Aug 19; 157(2):347-51. PubMed ID: 1853820 [Abstract] [Full Text] [Related]
20. Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcoma. Worth LL, Jaffe N, Benjamin RS, Papadopoulos NE, Patel S, Raymond AK, Jia SF, Rodriguez C, Gano J, Gianan MA, Kleinerman ES. Clin Cancer Res; 1997 Oct 19; 3(10):1721-9. PubMed ID: 9815556 [Abstract] [Full Text] [Related] Page: [Next] [New Search]